MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 1,200
- 试验地点
- 1
- 主要终点
- Waitlist Mortality
研究概览
简要总结
The purpose of the study is to study the muscle assessment score (MAsS, utilizing MRI, as an objective measure of frailty and muscle composition to serve as a predictor of morbidity and mortality in patients with liver disease.
详细描述
Prospective study of patients seen at the Univ. of Chicago Medical Center hospital and ambulatory clinics. The assessment of the MAsS score will require an additional 8-10 minutes in the MRI for each patient already undergoing MRI exam.
Four groups of pts. who are already scheduled for MRI for routine clinical purposes will be evaluated.
- Pts. hospitalized with acute hepatic decompensation for whom MRI is otherwise indicated for clinical evaluation.
- Pts. with hepatobiliary neoplasia
- Pts.undergoing transjugular portosystemic shunt (TIPS) placement
- Pts. with chronic liver disease undergoing magnetic resonance elastography for routine monitoring
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients who are already scheduled for an MRI for routine clinical purposes will be evaluated
排除标准
- •<18 yrs. of age
结局指标
主要结局
Waitlist Mortality
时间窗: Measured up to 10 years out from enrollment
Death prior to liver transplant or delisting from enrollment in the study
次要结局
未报告次要终点
